(Updated - August 12, 2014 11:16 AM EDT)

Canaccord Genuity initiated coverage on Sage Therapeutics (NASDAQ: SAGE) with a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS View New Coverage

Leerink Swann Starts Sage Therapeutics (SAGE) at OutperformAugust 12, 2014 7:46 AM JPMorgan Starts Sage Therapeutics (SAGE) at OverweightAugust 12, 2014 7:45 AM Goldman Sachs Starts Sage Therapeutics (SAGE) at NeutralAugust 12, 2014 7:44 AM